Simultaneous treatment with AICAR plus LY294002 strongly inhibited the self-renewal (Supplementary Fig. 4a), migration (Supplementary Fig. 4b), and invasion abilities of ENO1-overexpressing GC cells (Supplementary Fig. 4c). This evidence concerns the gene ENO1 and gastric cancer.